Join the Strattera group to help and get support from people like you.
Strattera News
FDA Medwatch Alert: Methylphenidate ADHD Medications: Drug Safety Communication - Risk of Long-lasting Erections
ISSUE: FDA is warning that methylphenidate products (including Concerta, Daytrana, Focalin/Focalin XR, Metadate CD/Metadate ER, Methylin/Methylin ER, Quillivant XR, Ritalin/Ritalin LA/Ritalin SR),...
FDA Medwatch Alert: Strattera (atomoxetine) - Sep 29, 2005
[Posted 09/29/2005] The FDA directed Eli Lilly and Company (Lilly), the manufacturer of Strattera (atomoxetine), to revise the prescribing information to include a boxed warning and additional...
FDA Medwatch Alert: Strattera (atomoxetine) - Dec 21, 2004
FDA notified health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and children. The labeling is being updated...
Further information
Related condition support groups
Attention-Deficit Hyperactivity Disorder (ADHD)